Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 93, Issue 2, Pages 90-102Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2014.10.001
Keywords
Biomarkers; Non-small cell; Small cell; Circulating tumor cells; Lung cancer
Categories
Ask authors/readers for more resources
There is increasing evidence for the use of circulating tumor cells (CTCs) as a liquid biopsy for early detection of lung cancer recurrence, prognosticating disease and monitoring treatment response. Further, CTC molecular analysis and interrogation of single cells hold significant potential in providing insights into tumor biology and the metastatic process. Ongoing research will likely see the translation of CTCs as a prognostic and predictive biomarker in both small cell, and non-small cell, lung cancer to routine clinical practice. Crown Copyright (C) 2014 Published by Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available